Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis

Background Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology Vol. 49; no. 2; pp. 295 - 304
Main Authors Imajo, Kento, Yoneda, Masato, Fujita, Koji, Kessoku, Takaomi, Tomeno, Wataru, Ogawa, Yuji, Shinohara, Yoshiyasu, Sekino, Yusuke, Mawatari, Hironori, Nozaki, Yuichi, Kirikoshi, Hiroyuki, Taguri, Masataka, Toshima, Gen, Takahashi, Junichiro, Saito, Satoru, Wada, Koichiro, Nakajima, Atsushi
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.02.2014
Springer
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0944-1174
1435-5922
1435-5922
DOI10.1007/s00535-013-0776-3

Cover

Abstract Background Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Methods Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Results Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Conclusions Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.
AbstractList Background Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Methods Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Results Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Conclusions Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.
Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis.BACKGROUNDAlthough therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis.Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline).METHODSSixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline).Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD.RESULTSFour-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD.Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.CONCLUSIONSFour-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.
Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was >=0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.[PUBLICATION ABSTRACT]
Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.
Background Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Methods Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Results Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was [greater than or equal to]0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Conclusions Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.
Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was [greater than or equal to]0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.
Audience Academic
Author Saito, Satoru
Takahashi, Junichiro
Nozaki, Yuichi
Fujita, Koji
Mawatari, Hironori
Imajo, Kento
Toshima, Gen
Wada, Koichiro
Tomeno, Wataru
Kessoku, Takaomi
Shinohara, Yoshiyasu
Ogawa, Yuji
Kirikoshi, Hiroyuki
Nakajima, Atsushi
Yoneda, Masato
Sekino, Yusuke
Taguri, Masataka
Author_xml – sequence: 1
  givenname: Kento
  surname: Imajo
  fullname: Imajo, Kento
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 2
  givenname: Masato
  surname: Yoneda
  fullname: Yoneda, Masato
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 3
  givenname: Koji
  surname: Fujita
  fullname: Fujita, Koji
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 4
  givenname: Takaomi
  surname: Kessoku
  fullname: Kessoku, Takaomi
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 5
  givenname: Wataru
  surname: Tomeno
  fullname: Tomeno, Wataru
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 6
  givenname: Yuji
  surname: Ogawa
  fullname: Ogawa, Yuji
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 7
  givenname: Yoshiyasu
  surname: Shinohara
  fullname: Shinohara, Yoshiyasu
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 8
  givenname: Yusuke
  surname: Sekino
  fullname: Sekino, Yusuke
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 9
  givenname: Hironori
  surname: Mawatari
  fullname: Mawatari, Hironori
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 10
  givenname: Yuichi
  surname: Nozaki
  fullname: Nozaki, Yuichi
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 11
  givenname: Hiroyuki
  surname: Kirikoshi
  fullname: Kirikoshi, Hiroyuki
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 12
  givenname: Masataka
  surname: Taguri
  fullname: Taguri, Masataka
  organization: Division of Biostatistics and Epidemiology, Yokohama City University Graduate School of Medicine
– sequence: 13
  givenname: Gen
  surname: Toshima
  fullname: Toshima, Gen
  organization: Skylight Biotech, Inc
– sequence: 14
  givenname: Junichiro
  surname: Takahashi
  fullname: Takahashi, Junichiro
  organization: Skylight Biotech, Inc
– sequence: 15
  givenname: Satoru
  surname: Saito
  fullname: Saito, Satoru
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 16
  givenname: Koichiro
  surname: Wada
  fullname: Wada, Koichiro
  organization: Department of Pharmacology, Graduate School of Dentistry, Osaka University
– sequence: 17
  givenname: Atsushi
  surname: Nakajima
  fullname: Nakajima, Atsushi
  email: nakajima-tky@umin.ac.jp
  organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23503837$$D View this record in MEDLINE/PubMed
BookMark eNp9kV1rVDEQhoNU7Lb6A7yRA954c2o-T3IuS9EqFHqj1yEnmbObkk3WJLvgv2-O2_pRVALJMDzvTGbeM3QSUwSEXhN8QTCW7wvGgokeE9ZjKYeePUMrwltGjJSeoBUeOe8JkfwUnZVyhxuIhXqBTikTmCkmVwhuswmd3aTgI3Q1Bcgm2hZBqZ0pneliOkBod_TxYIo_QLeFukmum1Pudhmct9XH9UKYYNNSyXalgqlpAztTffXlJXo-m1Dg1cN7jr5-_PDl6lN_c3v9-erypreCjrWfmOQWKB-Jm8w4T4Nkwo2gBjwrR5V1MAgjlBKDUlYQgsk4MWGFm6QSdHDsHL071t3l9G3fRtBbXyyEYCKkfdGEjyMRmA-8oW-foHdpn9sIPyhFCeaY_qLWJoD2cU41G7sU1ZeScKE44Qt18ReqHQdbb5tns2_5PwRvHprvpy04vct-a_J3_ehLA8gRsDmVkmH-iRCsF-_10XvdLNWL95o1jXyisb62_afYfuPDf5X0qCytS1xD_m0X_xTdA33UwLY
CitedBy_id crossref_primary_10_1371_journal_pone_0115403
crossref_primary_10_33549_physiolres_933784
crossref_primary_10_3390_diagnostics10030129
crossref_primary_10_1002_cpt_66
crossref_primary_10_1016_j_molmet_2024_101874
crossref_primary_10_1016_j_jcmgh_2023_05_010
crossref_primary_10_1016_j_metabol_2016_12_013
crossref_primary_10_1007_s00535_016_1264_3
Cites_doi 10.1007/s00535-007-2060-x
10.1002/hep.22140
10.1007/s00535-007-2014-3
10.1055/s-2001-12925
10.1002/hep.21768
10.1186/1471-230X-8-53
10.7326/0003-4819-143-10-200511150-00009
10.1002/hep.21984
10.1055/s-0028-1091983
10.1002/hep.24376
10.1002/hep.20973
10.1055/s-0028-1091978
10.1002/hep.21327
10.1053/j.gastro.2005.03.084
10.1016/S0016-5085(99)70506-8
10.1111/j.1872-034X.2012.00976.x
10.1111/j.1572-0241.1999.01377.x
10.1111/j.1572-0241.2004.30159.x
10.1146/annurev.nu.14.070194.001413
10.1002/hep.23094
10.1148/radiology.211.1.r99ap15283
10.1002/hep.20223
10.1007/BF00280883
10.1080/13547500500421070
10.1002/hep.21223
10.1053/jhep.2003.50320
10.1002/hep.23050
10.1002/hep.20701
10.1111/j.1440-1746.2006.04447.x
10.2337/diacare.20.7.1183
10.1016/S0022-2275(20)30123-1
ContentType Journal Article
Copyright Springer Japan 2013
COPYRIGHT 2014 Springer
Springer Japan 2014
Copyright_xml – notice: Springer Japan 2013
– notice: COPYRIGHT 2014 Springer
– notice: Springer Japan 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7T5
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
FYUFA
GHDGH
H94
K9-
K9.
KB0
M0R
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1007/s00535-013-0776-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
Proquest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest One Academic Middle East (New)
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1435-5922
EndPage 304
ExternalDocumentID 3219137401
A714584142
23503837
10_1007_s00535_013_0776_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
28-
29K
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BKNYI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
D-I
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
K9-
KDC
KOV
KOW
KPH
LAS
LLZTM
M0R
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PCD
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
X7M
YLTOR
Z45
Z7U
Z7W
Z82
Z83
Z87
Z8O
Z8Q
Z8V
Z8W
Z91
ZMTXR
ZOVNA
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
PMFND
7T5
7XB
8FK
ABRTQ
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
PUEGO
ID FETCH-LOGICAL-c529t-b374ce2491dba9fb6735d9e860f8d28cde65a5885688c511019b35c5db78526d3
IEDL.DBID BENPR
ISSN 0944-1174
1435-5922
IngestDate Thu Sep 04 19:55:48 EDT 2025
Fri Aug 15 23:01:33 EDT 2025
Tue Jun 17 21:55:22 EDT 2025
Tue Jun 10 20:14:47 EDT 2025
Thu Apr 03 07:00:54 EDT 2025
Thu Apr 24 23:11:46 EDT 2025
Tue Jul 01 04:34:10 EDT 2025
Fri Feb 21 02:29:32 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords OCTT
NAFLD
NASH
Plasma free choline levels
Noninvasive test
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c529t-b374ce2491dba9fb6735d9e860f8d28cde65a5885688c511019b35c5db78526d3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 23503837
PQID 1498210402
PQPubID 33411
PageCount 10
ParticipantIDs proquest_miscellaneous_1499150464
proquest_journals_1498210402
gale_infotracmisc_A714584142
gale_infotracacademiconefile_A714584142
pubmed_primary_23503837
crossref_primary_10_1007_s00535_013_0776_3
crossref_citationtrail_10_1007_s00535_013_0776_3
springer_journals_10_1007_s00535_013_0776_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-02-01
PublicationDateYYYYMMDD 2014-02-01
PublicationDate_xml – month: 02
  year: 2014
  text: 2014-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Journal of gastroenterology
PublicationTitleAbbrev J Gastroenterol
PublicationTitleAlternate J Gastroenterol
PublicationYear 2014
Publisher Springer Japan
Springer
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer
– name: Springer Nature B.V
References Brunt, Janney, Di Bisceglie, Neuschwander-Tetri, Bacon (CR13) 1999; 94
Guha, Parkes, Roderick, Chattopadhyay, Cross, Harris, Kaye (CR6) 2009; 47
Matteoni, Younossi, Gramlich, Boparai, Liu, McCullough (CR11) 1999; 116
(CR16) 1997; 20
Fujita, Nozaki, Wada, Yoneda, Fujimoto, Fujitake, Endo (CR9) 2009; 50
Yoneda, Uchiyama, Kato, Endo, Fujita, Yoneda, Mawatari (CR31) 2008; 8
Farrell, Larter (CR1) 2006; 43
Imajo, Fujita, Yoneda, Shinohara, Suzuki, Mawatari, Takahashi (CR10) 2012; 42
Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (CR15) 1985; 28
Sanyal, Brunt, Kleiner, Kowdley, Chalasani, Lavine (CR18) 2011; 54
Ratziu, Charlotte, Heurtier, Gombert, Giral, Bruckert (CR36) 2005; 128
Guha, Parkes, Roderick, Chattopadhyay, Cross, Harris, Kaye (CR26) 2009; 47
Yoneda, Mawatari, Fujita, Iida, Yonemitsu, Kato, Takahashi (CR30) 2007; 42
Younossi, Gramlich, Liu, Matteoni, Petrelli, Goldblum, Rybicki (CR4) 1998; 11
Ludwig, Viggiano, McGill, Oh (CR22) 1980; 55
Brunt (CR12) 2001; 21
Matteoni, Younossi, Gramlich, Boparani, Liu, McCullough (CR5) 1999; 116
Wieckowska, Zein, Yerian, Lopez, McCullough, Feldstein (CR32) 2006; 44
Feldstein, Wieckowska, Lopez, Liu, Zein, McCullough (CR33) 2009; 50
Hui, Kench, Chitturi, Sud, Farrell, Byth, Hall (CR21) 2003; 38
Yoneda, Mawatari, Fujita, Yonemitsu, Kato, Takahashi, Kirikoshi (CR34) 2007; 42
Ekstedt, Franzen, Mathiesen, Thorelius, Holmqvist, Bodemar, Kechagias (CR24) 2006; 44
Usui, Hara, Hosaki, Okazaki (CR17) 2002; 43
Kaneda, Hashimoto, Yatsuji, Tokushige, Shiratori (CR35) 2006; 21
Hamaguchi, Kojima, Takeda, Nagata, Takeda, Sarui, Kawahito (CR3) 2005; 143
Wieckowska, McCullough, Feldstein (CR25) 2007; 46
Brunt (CR19) 2001; 21
Solga, Alkhuraishe, Cope, Tabesh, Clark, Torbenson, Schwartz (CR28) 2006; 11
Chalasani, Deeg, Crabb (CR27) 2004; 99
Baranova, Younossi (CR7) 2008; 47
Wieckowska, Feldstein (CR8) 2008; 28
Yoshizumi, Nakamura, Yamane, Islam, Menju, Yamasaki, Arai (CR14) 1999; 211
Kleiner, Brunt, Van Natta, Behling, Contos, Cummings, Ferrell (CR20) 2005; 41
Zeisel, Blusztajn (CR23) 1994; 14
Lazo, Clark (CR2) 2008; 28
Hui, Farrell, Kench, George (CR29) 2004; 39
JM Hui (776_CR21) 2003; 38
AJ Sanyal (776_CR18) 2011; 54
V Ratziu (776_CR36) 2005; 128
American Diabetes Association (776_CR16) 1997; 20
SH Zeisel (776_CR23) 1994; 14
M Yoneda (776_CR30) 2007; 42
AE Feldstein (776_CR33) 2009; 50
A Baranova (776_CR7) 2008; 47
A Wieckowska (776_CR32) 2006; 44
M Yoneda (776_CR31) 2008; 8
T Yoshizumi (776_CR14) 1999; 211
ZM Younossi (776_CR4) 1998; 11
M Ekstedt (776_CR24) 2006; 44
M Lazo (776_CR2) 2008; 28
DR Matthews (776_CR15) 1985; 28
DE Kleiner (776_CR20) 2005; 41
N Chalasani (776_CR27) 2004; 99
GC Farrell (776_CR1) 2006; 43
S Usui (776_CR17) 2002; 43
H Kaneda (776_CR35) 2006; 21
M Hamaguchi (776_CR3) 2005; 143
K Imajo (776_CR10) 2012; 42
EM Brunt (776_CR13) 1999; 94
EM Brunt (776_CR19) 2001; 21
SF Solga (776_CR28) 2006; 11
IN Guha (776_CR6) 2009; 47
C Matteoni (776_CR5) 1999; 116
CA Matteoni (776_CR11) 1999; 116
M Yoneda (776_CR34) 2007; 42
IN Guha (776_CR26) 2009; 47
EM Brunt (776_CR12) 2001; 21
A Wieckowska (776_CR25) 2007; 46
JM Hui (776_CR29) 2004; 39
A Wieckowska (776_CR8) 2008; 28
K Fujita (776_CR9) 2009; 50
J Ludwig (776_CR22) 1980; 55
15122781 - Hepatology. 2004 May;39(5):1458-9
15307867 - Am J Gastroenterol. 2004 Aug;99(8):1497-502
17006923 - Hepatology. 2006 Oct;44(4):865-73
21520200 - Hepatology. 2011 Jul;54(1):344-53
16287793 - Ann Intern Med. 2005 Nov 15;143(10 ):722-8
19585618 - Hepatology. 2009 Oct;50(4):1072-8
16799979 - Hepatology. 2006 Jul;44(1):27-33
15940625 - Gastroenterology. 2005 Jun;128(7):1898-906
10189485 - Radiology. 1999 Apr;211(1):283-6
10484010 - Am J Gastroenterol. 1999 Sep;94(9):2467-74
9647594 - Mod Pathol. 1998 Jun;11(6):560-5
19014569 - BMC Gastroenterol. 2008 Nov 14;8:53
15915461 - Hepatology. 2005 Jun;41(6):1313-21
11296695 - Semin Liver Dis. 2001;21(1):3-16
10348825 - Gastroenterology. 1999 Jun;116(6):1413-9
11971952 - J Lipid Res. 2002 May;43(5):805-14
18038452 - Hepatology. 2008 Feb;47(2):455-60
16911693 - J Gastroenterol Hepatol. 2006 Sep;21(9):1459-65
18956290 - Semin Liver Dis. 2008 Nov;28(4):339-50
7946521 - Annu Rev Nutr. 1994;14:269-96
16447287 - Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112
17530362 - J Gastroenterol. 2007 May;42(5):375-81
19650159 - Hepatology. 2009 Sep;50(3):772-80
7382552 - Mayo Clin Proc. 1980 Jul;55(7):434-8
3899825 - Diabetologia. 1985 Jul;28(7):412-9
17653654 - J Gastroenterol. 2007 Jul;42(7):573-82
18956295 - Semin Liver Dis. 2008 Nov;28(4):386-95
9203460 - Diabetes Care. 1997 Jul;20(7):1183-97
17661414 - Hepatology. 2007 Aug;46(2):582-9
12883486 - Hepatology. 2003 Aug;38(2):420-7
22780848 - Hepatol Res. 2012 Aug;42(8):757-66
16766393 - Biomarkers. 2006 Mar-Apr;11(2):174-83
18220279 - Hepatology. 2008 Feb;47(2):373-5
References_xml – volume: 42
  start-page: 573
  year: 2007
  end-page: 582
  ident: CR30
  article-title: High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-007-2060-x
– volume: 47
  start-page: 373
  year: 2008
  end-page: 375
  ident: CR7
  article-title: The future is around the corner: noninvasive diagnosis of the progressive nonalcoholic steatohepatitis
  publication-title: Hepatology
  doi: 10.1002/hep.22140
– volume: 42
  start-page: 375
  year: 2007
  end-page: 381
  ident: CR34
  article-title: Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-007-2014-3
– volume: 21
  start-page: 3
  year: 2001
  end-page: 16
  ident: CR12
  article-title: Nonalcoholic steatohepatitis: definition and pathology
  publication-title: Semin Liver Dis
  doi: 10.1055/s-2001-12925
– volume: 46
  start-page: 582
  year: 2007
  end-page: 589
  ident: CR25
  article-title: Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future
  publication-title: Hepatology
  doi: 10.1002/hep.21768
– volume: 8
  start-page: 53
  year: 2008
  end-page: 61
  ident: CR31
  article-title: Plasma pentraxin 3 is a novel marker for nonalcoholic steatohepatitis (NASH)
  publication-title: BMC Gastroenterol
  doi: 10.1186/1471-230X-8-53
– volume: 143
  start-page: 722
  year: 2005
  end-page: 728
  ident: CR3
  article-title: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-143-10-200511150-00009
– volume: 55
  start-page: 434
  year: 1980
  end-page: 438
  ident: CR22
  article-title: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
  publication-title: Mayo Clin Proc
– volume: 47
  start-page: 455
  year: 2009
  end-page: 460
  ident: CR26
  article-title: Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers
  publication-title: Hepatology
  doi: 10.1002/hep.21984
– volume: 28
  start-page: 386
  year: 2008
  end-page: 395
  ident: CR8
  article-title: Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0028-1091983
– volume: 54
  start-page: 344
  year: 2011
  end-page: 353
  ident: CR18
  article-title: Endpoints and clinical trial design for nonalcoholic steatohepatitis
  publication-title: Hepatology
  doi: 10.1002/hep.24376
– volume: 43
  start-page: 99
  year: 2006
  end-page: 112
  ident: CR1
  article-title: Nonalcoholic fatty liver disease: from steatosis to cirrhosis
  publication-title: Hepatology
  doi: 10.1002/hep.20973
– volume: 28
  start-page: 339
  year: 2008
  end-page: 350
  ident: CR2
  article-title: The epidemiology of nonalcoholic fatty liver disease: a global perspective
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0028-1091978
– volume: 44
  start-page: 865
  year: 2006
  end-page: 873
  ident: CR24
  article-title: Long-term follow-up of patients with NAFLD and elevated liver enzymes
  publication-title: Hepatology
  doi: 10.1002/hep.21327
– volume: 128
  start-page: 1898
  year: 2005
  end-page: 1906
  ident: CR36
  article-title: Sampling variability of liver biopsy in nonalcoholic fatty liver disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.03.084
– volume: 116
  start-page: 1413
  year: 1999
  end-page: 1419
  ident: CR5
  article-title: A non-alcoholic fatty liver disease: a spectrum of clinical and pathologic severity
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(99)70506-8
– volume: 42
  start-page: 757
  year: 2012
  end-page: 766
  ident: CR10
  article-title: Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: a multi-center validation study
  publication-title: Hepatol Res
  doi: 10.1111/j.1872-034X.2012.00976.x
– volume: 94
  start-page: 2467
  year: 1999
  end-page: 2474
  ident: CR13
  article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.1999.01377.x
– volume: 11
  start-page: 560
  year: 1998
  end-page: 565
  ident: CR4
  article-title: Non-alcoholic fatty liver: assessment of variability in the pathologic interpretations
  publication-title: Mod Pathol
– volume: 99
  start-page: 1497
  year: 2004
  end-page: 1502
  ident: CR27
  article-title: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2004.30159.x
– volume: 43
  start-page: 805
  year: 2002
  end-page: 814
  ident: CR17
  article-title: A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC
  publication-title: J Lipid Res
– volume: 20
  start-page: 1183
  year: 1997
  end-page: 1197
  ident: CR16
  article-title: Report of the expert committee on the diagnosis and classification of diabetes mellitus
  publication-title: Diabetes Care
– volume: 14
  start-page: 269
  year: 1994
  end-page: 296
  ident: CR23
  article-title: Choline and human nutrition
  publication-title: Annu Rev Nutr
  doi: 10.1146/annurev.nu.14.070194.001413
– volume: 50
  start-page: 772
  year: 2009
  end-page: 780
  ident: CR9
  article-title: Dysfunctional very-low density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
  publication-title: Hepatology
  doi: 10.1002/hep.23094
– volume: 211
  start-page: 283
  year: 1999
  end-page: 286
  ident: CR14
  article-title: Abdominal fat: standardized technique for measurement at CT
  publication-title: Radiology
  doi: 10.1148/radiology.211.1.r99ap15283
– volume: 39
  start-page: 1458
  year: 2004
  end-page: 1459
  ident: CR29
  article-title: High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD
  publication-title: Hepatology
  doi: 10.1002/hep.20223
– volume: 47
  start-page: 455
  year: 2009
  end-page: 460
  ident: CR6
  article-title: Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers
  publication-title: Hepatology
  doi: 10.1002/hep.21984
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  ident: CR15
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 21
  start-page: 3
  year: 2001
  end-page: 16
  ident: CR19
  article-title: Nonalcoholic steatohepatitis: definition and pathology
  publication-title: Semin Liver Dis
  doi: 10.1055/s-2001-12925
– volume: 11
  start-page: 174
  year: 2006
  end-page: 183
  ident: CR28
  article-title: Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations
  publication-title: Biomarkers
  doi: 10.1080/13547500500421070
– volume: 44
  start-page: 27
  year: 2006
  end-page: 33
  ident: CR32
  article-title: In vivo assessment of liver cell apoptosis as a novel biomarker of disease sensitivity in nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.21223
– volume: 21
  start-page: 1459
  year: 2006
  end-page: 1465
  ident: CR35
  article-title: Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease
  publication-title: J Gastroenterol Hepatol
– volume: 38
  start-page: 420
  year: 2003
  end-page: 427
  ident: CR21
  article-title: Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50320
– volume: 50
  start-page: 1072
  year: 2009
  end-page: 1078
  ident: CR33
  article-title: Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study
  publication-title: Hepatology
  doi: 10.1002/hep.23050
– volume: 41
  start-page: 1313
  year: 2005
  end-page: 1321
  ident: CR20
  article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.20701
– volume: 116
  start-page: 1413
  year: 1999
  end-page: 1419
  ident: CR11
  article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(99)70506-8
– volume: 11
  start-page: 174
  year: 2006
  ident: 776_CR28
  publication-title: Biomarkers
  doi: 10.1080/13547500500421070
– volume: 116
  start-page: 1413
  year: 1999
  ident: 776_CR5
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(99)70506-8
– volume: 43
  start-page: 99
  year: 2006
  ident: 776_CR1
  publication-title: Hepatology
  doi: 10.1002/hep.20973
– volume: 21
  start-page: 3
  year: 2001
  ident: 776_CR19
  publication-title: Semin Liver Dis
  doi: 10.1055/s-2001-12925
– volume: 47
  start-page: 455
  year: 2009
  ident: 776_CR26
  publication-title: Hepatology
  doi: 10.1002/hep.21984
– volume: 116
  start-page: 1413
  year: 1999
  ident: 776_CR11
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(99)70506-8
– volume: 94
  start-page: 2467
  year: 1999
  ident: 776_CR13
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.1999.01377.x
– volume: 21
  start-page: 3
  year: 2001
  ident: 776_CR12
  publication-title: Semin Liver Dis
  doi: 10.1055/s-2001-12925
– volume: 44
  start-page: 865
  year: 2006
  ident: 776_CR24
  publication-title: Hepatology
  doi: 10.1002/hep.21327
– volume: 44
  start-page: 27
  year: 2006
  ident: 776_CR32
  publication-title: Hepatology
  doi: 10.1002/hep.21223
– volume: 46
  start-page: 582
  year: 2007
  ident: 776_CR25
  publication-title: Hepatology
  doi: 10.1002/hep.21768
– volume: 55
  start-page: 434
  year: 1980
  ident: 776_CR22
  publication-title: Mayo Clin Proc
– volume: 21
  start-page: 1459
  year: 2006
  ident: 776_CR35
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2006.04447.x
– volume: 47
  start-page: 373
  year: 2008
  ident: 776_CR7
  publication-title: Hepatology
  doi: 10.1002/hep.22140
– volume: 50
  start-page: 772
  year: 2009
  ident: 776_CR9
  publication-title: Hepatology
  doi: 10.1002/hep.23094
– volume: 47
  start-page: 455
  year: 2009
  ident: 776_CR6
  publication-title: Hepatology
  doi: 10.1002/hep.21984
– volume: 128
  start-page: 1898
  year: 2005
  ident: 776_CR36
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.03.084
– volume: 38
  start-page: 420
  year: 2003
  ident: 776_CR21
  publication-title: Hepatology
– volume: 211
  start-page: 283
  year: 1999
  ident: 776_CR14
  publication-title: Radiology
  doi: 10.1148/radiology.211.1.r99ap15283
– volume: 8
  start-page: 53
  year: 2008
  ident: 776_CR31
  publication-title: BMC Gastroenterol
  doi: 10.1186/1471-230X-8-53
– volume: 41
  start-page: 1313
  year: 2005
  ident: 776_CR20
  publication-title: Hepatology
  doi: 10.1002/hep.20701
– volume: 28
  start-page: 412
  year: 1985
  ident: 776_CR15
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 42
  start-page: 757
  year: 2012
  ident: 776_CR10
  publication-title: Hepatol Res
  doi: 10.1111/j.1872-034X.2012.00976.x
– volume: 20
  start-page: 1183
  year: 1997
  ident: 776_CR16
  publication-title: Diabetes Care
  doi: 10.2337/diacare.20.7.1183
– volume: 14
  start-page: 269
  year: 1994
  ident: 776_CR23
  publication-title: Annu Rev Nutr
  doi: 10.1146/annurev.nu.14.070194.001413
– volume: 42
  start-page: 573
  year: 2007
  ident: 776_CR30
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-007-2060-x
– volume: 39
  start-page: 1458
  year: 2004
  ident: 776_CR29
  publication-title: Hepatology
  doi: 10.1002/hep.20223
– volume: 43
  start-page: 805
  year: 2002
  ident: 776_CR17
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)30123-1
– volume: 54
  start-page: 344
  year: 2011
  ident: 776_CR18
  publication-title: Hepatology
  doi: 10.1002/hep.24376
– volume: 42
  start-page: 375
  year: 2007
  ident: 776_CR34
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-007-2014-3
– volume: 143
  start-page: 722
  year: 2005
  ident: 776_CR3
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-143-10-200511150-00009
– volume: 50
  start-page: 1072
  year: 2009
  ident: 776_CR33
  publication-title: Hepatology
  doi: 10.1002/hep.23050
– volume: 28
  start-page: 339
  year: 2008
  ident: 776_CR2
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0028-1091978
– volume: 99
  start-page: 1497
  year: 2004
  ident: 776_CR27
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2004.30159.x
– volume: 28
  start-page: 386
  year: 2008
  ident: 776_CR8
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0028-1091983
– volume: 11
  start-page: 560
  year: 1998
  ident: 776_CR4
  publication-title: Mod Pathol
– reference: 19585618 - Hepatology. 2009 Oct;50(4):1072-8
– reference: 16766393 - Biomarkers. 2006 Mar-Apr;11(2):174-83
– reference: 22780848 - Hepatol Res. 2012 Aug;42(8):757-66
– reference: 15940625 - Gastroenterology. 2005 Jun;128(7):1898-906
– reference: 18956290 - Semin Liver Dis. 2008 Nov;28(4):339-50
– reference: 7946521 - Annu Rev Nutr. 1994;14:269-96
– reference: 11971952 - J Lipid Res. 2002 May;43(5):805-14
– reference: 11296695 - Semin Liver Dis. 2001;21(1):3-16
– reference: 15915461 - Hepatology. 2005 Jun;41(6):1313-21
– reference: 10189485 - Radiology. 1999 Apr;211(1):283-6
– reference: 15122781 - Hepatology. 2004 May;39(5):1458-9
– reference: 10348825 - Gastroenterology. 1999 Jun;116(6):1413-9
– reference: 15307867 - Am J Gastroenterol. 2004 Aug;99(8):1497-502
– reference: 7382552 - Mayo Clin Proc. 1980 Jul;55(7):434-8
– reference: 16911693 - J Gastroenterol Hepatol. 2006 Sep;21(9):1459-65
– reference: 12883486 - Hepatology. 2003 Aug;38(2):420-7
– reference: 19650159 - Hepatology. 2009 Sep;50(3):772-80
– reference: 10484010 - Am J Gastroenterol. 1999 Sep;94(9):2467-74
– reference: 17530362 - J Gastroenterol. 2007 May;42(5):375-81
– reference: 9203460 - Diabetes Care. 1997 Jul;20(7):1183-97
– reference: 16799979 - Hepatology. 2006 Jul;44(1):27-33
– reference: 9647594 - Mod Pathol. 1998 Jun;11(6):560-5
– reference: 18220279 - Hepatology. 2008 Feb;47(2):373-5
– reference: 16447287 - Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112
– reference: 16287793 - Ann Intern Med. 2005 Nov 15;143(10 ):722-8
– reference: 18038452 - Hepatology. 2008 Feb;47(2):455-60
– reference: 17006923 - Hepatology. 2006 Oct;44(4):865-73
– reference: 3899825 - Diabetologia. 1985 Jul;28(7):412-9
– reference: 17653654 - J Gastroenterol. 2007 Jul;42(7):573-82
– reference: 19014569 - BMC Gastroenterol. 2008 Nov 14;8:53
– reference: 21520200 - Hepatology. 2011 Jul;54(1):344-53
– reference: 17661414 - Hepatology. 2007 Aug;46(2):582-9
– reference: 18956295 - Semin Liver Dis. 2008 Nov;28(4):386-95
SSID ssj0013058
Score 2.109596
Snippet Background Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the...
Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease,...
Background Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 295
SubjectTerms Abdominal Surgery
Administration, Oral
Adult
Aged
Area Under Curve
Biliary Tract
Case-Control Studies
Choline
Choline - administration & dosage
Choline - blood
Colorectal Surgery
Ethylenediaminetetraacetic acid
Evaluation
Fasting
Fatty Liver - blood
Fatty Liver - diagnosis
Female
Fibrosis
Gastroenterology
Health aspects
Hepatology
Humans
Lipoproteins, VLDL - blood
Lipotropic Agents - administration & dosage
Lipotropic Agents - blood
Liver
Liver - pathology
Liver diseases
Male
Medical colleges
Medicine
Medicine & Public Health
Methods
Middle Aged
Non-alcoholic Fatty Liver Disease
Original Article—Liver
Pancreas
Physiological aspects
Predictive Value of Tests
ROC Curve
Surgical Oncology
Time Factors
Triglycerides - blood
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1ra9RAcNAriF98P1KrrCAISkqSfWT34yGtRal-aaF-Cvs6PDxy5S7XD_76zuRl71ChX0LCzm72MTM7szM7A_CuwE0jWCTAGaIDKihOplrwkBqy-kWXGe_paOD0mzo5F18u5EV_j3s9eLsPJsmWU4-X3dpQJGmbjaAsVcrvwp7MtdET2Jt-_vH16I_xIGvTcqLiItIcJe7BmPm3Rra2o12mfGNX2jGTtrvP8UM4G_rdOZ38Otw07tD_3gnpeMuBPYIHvTTKph36PIY7sX4C9057e_tTiN9XWEwcEj9Zs1xEysOBb9htZtfMsnp5FRf4rOf1lSVXeNblpGYoDLPLFbVEjtUEYbtsvHPPCLOa5c9I3tzNfP0Mzo-Pzj6dpH1ihtTLwjSp46XwERW3PDhrZk6VXAYTtcpmOhTah6iklVpLpbVHiQ7FSMell8GVWhYq8Ocwwd_Gl8CidkIYOkrB1ZLa2MBV9CF4H2TmsyyBbFifyvdRyyl5xqIa4y2301fh9FU0fRVP4MNY5bIL2fE_4Pe06BWRM7brbX8rAXtHgbGqaZmTJTkXRQIHW5BIhn67eECbqmcDa9SrjEadGnX0BN6OxVSTXNvquNy0MAalcqFEAi86dBu7XXCK1sPLBD4OqHOj8X-Naf9W0K_gPgqBovNEP4BJs9rE1yhoNe5NT1jX5u8baQ
  priority: 102
  providerName: Springer Nature
Title Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis
URI https://link.springer.com/article/10.1007/s00535-013-0776-3
https://www.ncbi.nlm.nih.gov/pubmed/23503837
https://www.proquest.com/docview/1498210402
https://www.proquest.com/docview/1499150464
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED_aBsZeytZ91FsXNBgMNswcS7LlhzGSkaxsNBtjgezJ6Cs0EOwscfv3784faVNoX5IYybJyvjv9Tne6A3gX46LhNArgAtkBDRQjQyW4CzPy-nkTZdbS1sDFNDmfie9zOT-AaXcWhsIqO51YK2pXWtoj_4RIXqF5gubOl_W_kKpGkXe1K6Gh29IK7nOdYuwQeqiSFfJ9bzSe_vp941eI6oqdaNOIcIBgvPNzRnVaUckpkI2HlOIm5Hsr1V19fWvBuuNBrRemyRM4bhElGzYs8BQOfHECjy5an_kz8D832ExaDi9ZVa481dLAXzg-01umWVFe-xV-FsviWlM4O2vqSjMEtGy9oZEoOJp66Kai7tIy4o6qvPQUkV0tt89hNhn_-XoetsUVQivjrAoNT4X1aHwNnNHZwiQply7zKokWysXKOp9ILZWSiVIWURlCQcOllc6kSsaJ4y_gCB_rT4F5ZYTIaDsEySpVph1PvHXOWicjG0UBRB0hc9tmHqcCGKt8lzO5pn2OtM-J9jkP4MPulnWTduOhzu_p7eQkkjiu1e3JApwdJbfKh-mAvMEDEQdwttcTRcnuN3fvN29FeZvfMF4Ab3fNdCeFpxW-vKr7ZIisRSICeNnwxW7aMaeMOzwN4GPHKLcGv-8_vXp4Kq_hMSI30YSPn8FRtbnybxAdVaYPh-k87UNvOBmNpvT97e-Pcb8VBGydxcP_3lANeA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DQ6CXhBfBMYYCQQEigije3EeZjQgE0dWwtCm7Q3z7FdrVKVdG02xJ_jt3GXj26dxN72EiWyc3HO5_vwne8A3sYoNJzBBThGckADJZehEtyFGXn9fB5l1tLWwHCUDA7F9yN5tAZ_u7MwFFbZ8cSaUbvS0h75J9TkFZonaO58np2GVDWKvKtdCQ3TllZwm3WKsfZgx57_8xtNuMXm7jec73dxvLN98HUQtlUGQivjrApzngrr0Qrpu9xk4zxJuXSZV0k0Vi5W1vlEGqmUTJSyqJ6gTpRzaaXLUyXjxHGEewvWBZ1w7cH6l-3Rz18XfoyorhCKNpQI-6j8d37VqE5jKjkFzvGQUuqEfEUyXpUPlwTkFY9tLQh37sO9VoNlWw3JPYA1XzyE28PWR_8I_I85NhNXxUdWlVNPtTvwDuEzs2CGFeW5n-K1mBTnhsLnWVPHmqECzWZzgkTB2NTDNBV8J5YRNVbliacI8GqyeAyHN4LmJ9DDz_pnwLzKhcho-wXRKlVmHE-8dc5aJyMbRQFEHSK1bTOdU8GNqV7maK5xrxH3mnCveQAflq_MmjQf13V-T7OjiQUgXGvakww4OkqmpbfSPnmf-yIOYGOlJy5du9rcza9uWcdCXxB6AG-WzfQmhcMVvjyr-2SoyYtEBPC0oYvlsGNOGX54GsDHjlAuAf_fPz2_fiiv4c7gYLiv93dHey_gLmqNogld34BeNT_zL1Ezq_JXLfkzOL7pFfcP-StE0w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9QwzBpDmnhBjM_CNoIEQgJVyzVJmz6gaWKcNsYGD0y6t9B8nDjp1B533RB_jV-H3Y_bbhJ720vVKombOnZsx64N8DpBoeELZMAxkgMaKFbFWgof5-T1C5bnztHRwMlpengmP4_UaA3-9v_CUFhlvyc2G7WvHJ2R76Imr9E8QXNnd9yFRXw7GO7NfsVUQYo8rX05jZZEjsOf32i-LT4cHeBav0mS4afvHw_jrsJA7FSS17EVmXQBLZCBt0U-tmkmlM-DTvlY-0Q7H1JVKK1VqrVD1QT1ISuUU95mWiWpFwj3DtzFUZwMv2yUXXoweFMbFK0nGQ9Q7e89qrxJYKoEhcyJmJLpxGJFJl6XDFdE4zVfbSMChw_gfqe7sv2W2DZhLZQPYeOk884_gvB1js20n-Ijq6tpoKodeIfwWbFgBSurizDFazkpLwoKnGdtBWuGqjObzQkShWFTj6Kt3TtxjOiwrn4Giv2uJ4vHcHYrSH4C6_ja8AxY0FbKnA5eEK1K54UXaXDeO-cVd5xHwHtEGtflOKdSG1OzzM7c4N4g7g3h3ogI3i2HzNoEHzd1fkurY4j5Ea4run8YcHaURsvsZwPyOw9kEsHWSk9kWrfa3K-v6TaNhbkk8QheLZtpJAXClaE6b_rkqMPLVEbwtKWL5bQTQbl9RBbB-55QrgD_3zc9v3kqL2ED-cx8OTo9fgH3UF2Ubcz6FqzX8_OwjSpZbXca2mfw47aZ7R_v60Jp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+choline+tolerance+test+as+a+novel+noninvasive+method+for+predicting+nonalcoholic+steatohepatitis&rft.jtitle=Journal+of+gastroenterology&rft.au=Imajo%2C+Kento&rft.au=Yoneda%2C+Masato&rft.au=Fujita%2C+Koji&rft.au=Kessoku%2C+Takaomi&rft.date=2014-02-01&rft.eissn=1435-5922&rft.volume=49&rft.issue=2&rft.spage=295&rft_id=info:doi/10.1007%2Fs00535-013-0776-3&rft_id=info%3Apmid%2F23503837&rft.externalDocID=23503837
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0944-1174&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0944-1174&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0944-1174&client=summon